Exelixis at a glance
exelixis.com- Founded 1994
- Ticker EXEL
- Revenue (FY2025) $2.32B
- Net income $782.57M
Investor research: Yahoo Finance · SEC filings
Federal funding recipient: largest known award $76K from the Department of Veterans Affairs (started Nov 22, 2016) — via USAspending.gov
Source: Wikipedia

Exelixis
Join Exelixis in Alameda, Alameda County as an Associate Regulatory Affairs Strategy Director, where you'll develop and execute global regulatory strategies that advance our oncology therapies while meeting evolving health authority requirements.
About the Role
This full-time position offers strategic leadership in regulatory affairs, working closely with cross-functional teams to navigate complex global health authority landscapes. You'll ensure our regulatory submissions are scientifically sound, strategically aligned with asset and corporate objectives, and positioned for success in international markets.
What You'll Do
- Develop and implement global regulatory strategies that support oncology asset progression from development through commercialization
- Lead preparation and submission of regulatory documentation to health authorities worldwide, maintaining scientific rigor and organizational consistency
- Translate regulatory requirements into clear, actionable timelines and implementation plans for internal stakeholders
- Partner with clinical, medical, and commercial teams to align regulatory strategy with asset and corporate goals
- Maintain current expertise in regulatory pathways and communicate regulatory landscape developments to key partners
- Manage regulatory milestones and submission schedules to support program advancement
What We're Looking For
- Deep expertise in regulatory affairs strategy within oncology drug development
- Proven track record leading global regulatory submissions and health authority engagement
- Strong knowledge of FDA, EMA, and international regulatory pathways for therapeutic drugs
- Excellent ability to translate complex regulatory concepts for diverse audiences
- Demonstrated leadership experience collaborating across functional teams
- Advanced degree in a scientific discipline or equivalent professional regulatory affairs experience
About Exelixis
Exelixis is a biopharmaceutical company committed to developing and commercializing novel therapies that address critical unmet medical needs in oncology and other therapeutic areas.
How to Apply
To apply, complete your application directly on this page, or you'll be redirected to the employer's application platform to finish submitting there.
To apply for this job please visit www.adzuna.com.
Explore Exelixis online
What people say about Exelixis
- Occurences of swearing in the Linux kernel source code over time
- Apple in code search profanity outrage (2006)
- Fck-nat: The (f)easible (C)ost (k)onfigurable NAT
- Open source code with profanity in comments is statistically better
Recent news
- Is Exelixis, Inc. (EXEL) Among the Best Under-the-Radar Stocks to Invest In? - Yahoo Finance
- Exelixis’ Cabometyx successor fails primary endpoint in colorectal cancer trial amid FDA review - Fierce Biotech
- Exelixis opens two-front patent dispute over Cabometyx copies - Life Sciences IP Review
- Exelixis Inc stock hits all-time high at 56.22 USD - Investing.com
- Handa, Intas Face Patent Suits Over Exelixis Cancer Drug - Law360
Aggregated from public discussions and news; opinions are the authors’ own.
Job details above are provided by the employer/source. The sections on this page are compiled from public data sources with AI assistance.
Accommodations: if you need a workplace accommodation to apply for or perform this job, see ADA.gov or EEOC.gov for guidance on your rights and how to request one.
Keep exploring on Get A Job.ai
Not quite the right fit? Your next opportunity is a click away.
- Browse all jobs
- More jobs by category
- Remote jobs you can do from anywhere
- Research typical pay for this role
- Set a job alert so new matches reach you first
- Upload your resume to apply faster
Hiring instead? Post a job and reach candidates searching right now.
